MedPath

Oblique Subcostal Tap Block Efficacy in Laparoscopic Cholecystectomy

Registration Number
NCT02707250
Lead Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Brief Summary

Laparoscopic cholecystectomy although a minimally invasive procedure, may be accompanied by considerable pain after surgery. More recently transversus abdominis plane (TAP) block was extensively studied as a potential analgesic maneuver after laparoscopic cholecystectomy. The subcostal approach (OSTAP block) is a variation on the TAP block that produces reliable supraumbilical analgesia.

Detailed Description

Laparoscopic cholecystectomy is a minimally invasive widespread surgical procedure, with postoperative lower pain scores and quick recovery of the patient. However some of patients may complain of considerable pain after surgery . There are several approaches to postoperative pain management after laparoscopic cholecystectomy such as patient-controlled analgesia with opioids (IV-PCA), neuraxial blocks, intraperitoneal injection of local anesthetics, wound infiltration, each being more or less effective, with specific side effects.

The transversus abdominis plane block (TAP-Block) is a regional analgesia technique that comes as an alternative to "classical" procedures of postoperative analgesia. Described by Rafi and McDonnell et al. this technique has undergone some changes over times, which increased its efficiency. Thus, Hebbard et al. described ultrasound subcostal oblique approach (OSTAP) of the block allowing analgesia in both the upper and lower abdomen, with a lower rate of complications due to the direct ultrasound visualization. Different studies confirmed the analgesic efficacy of this technique and the postoperative opioid sparing effect after laparoscopic cholecystectomy .

Traditionally, the transversus abdominis plane block is achieved with classical amino-amides local anesthetics, bupivacaine, levobupivacaine and ropivacaine being the most commonly used .

Based on the local anesthetic properties of pethidine, a synthetic opioid, our study aimed to evaluate prospectively the analgesic efficacy of pethidine in achieving transversus abdominis plane block by ultrasound oblique subcostal approach in patients scheduled for elective laparoscopic cholecystectomy.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • American Society of Anaesthesiologists (ASA) I-II
  • Age over 18years old
  • patients scheduled elective laparoscopic cholecystectomy
Exclusion Criteria
  • Open cholecystectomy - excluded due to increased levels of pain in open procedures
  • Renal dysfunction (Serum Cr > 1.2) - excluded due to potential altered metabolism of anesthetic and pain medications
  • Coagulopathy or anticoagulation - increased risk of bleeding from nerve block injection
  • Allergy or contraindication to any of the study medications or anesthetic agents
  • Chronic opioid analgesic use at home - excluded due to potential difficulty in assessing pain caused by the procedure alone
  • Patient inability to properly describe postoperative pain to investigators (language barrier, dementia, delirium, psychiatric disorder)
  • Pregnancy
  • Prisoners
  • Patient or surgeon refusal

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboOblique subcostal tap block with normal sterile saline ,20 ml, bilateral, single shot,24h
Pethidine Local Infiltration (L.I.)Pethidine Local Infiltration (L.I)Local infiltration of pethidine 1% at trocar insertion sites, 5ml /site, 24h compared with Tap Block with pethidine 1%
BupivacaineBupivacaineOblique subcostal tap block with bupivacaine 0,25% ,20 ml, bilateral, single shot,24h
PethidinePethidineOblique subcostal tap block with pethidine 1% ,10 ml,bilateral,single shot,24h
Primary Outcome Measures
NameTimeMethod
Pain ScoresRecorded 24 hours postoperative

This outcome is measured with a visual analogue scale (VAS, from 0 to 10) at 24 hours postoperative, while the patient is in his bed. This outcome is recorded in and compared between all four groups.

Secondary Outcome Measures
NameTimeMethod
Side effectsRecorded in the first 24 hours postoperative

nausea, vomiting, pruritus and sedation on a 4 point scale as none, mild, moderate and severe

Intraoperative fentanyl consumption0-4 hours

Recording total amount of intraoperative fentanyl consumption

Time to first opioid administration in Post Anesthetic Care Unit0-4 hours postoperative

Recording time to first opioid administration in post aesthetic care unit

Cumulative opioid consumptionRecorded in the first 24 hours perioperative period

Recording total amount of opioids used in postoperative period

Trial Locations

Locations (1)

Regional Institute of Gastroenterology and Hepatology "Prof.dr.Octavian Fodor"

🇷🇴

Cluj-Napoca, Cluj, Romania

© Copyright 2025. All Rights Reserved by MedPath